Currently, there are 1.81B common shares owned by the public and among those 1.71B shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of -2.50% and -5.02% over the past three months. SCHW shares are trading 5.55% year to date (YTD), with the 12-month market performance up to 18.99% higher. It has a 12-month low price of $61.01 and touched a high of $84.50 over the same period. SCHW has an average intraday trading volume of 10.33 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -3.64%, -0.28%, and 7.49% respectively.
Institutional ownership of Charles Schwab Corp (NYSE: SCHW) shares accounts for 83.60% of the company’s 1.81B shares outstanding.
It has a market capitalization of $145.65B and a beta (3y monthly) value of 0.98. The stock’s trailing 12-month PE ratio is 26.15, while the earnings-per-share (ttm) stands at $2.99. The company has a PEG of 1.10 and the debt-to-equity ratio at 0.93. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.49% over the week and 2.16% over the month.
Earnings per share for the fiscal year are expected to increase by 29.33%, and 23.80% over the next financial year. EPS should grow at an annualized rate of 23.87% over the next five years, compared to 2.28% over the past 5-year period.
Looking at the support for the SCHW, a number of firms have released research notes about the stock. TD Cowen stated their Buy rating for the stock in a research note on February 18, 2025, with the firm’s price target at $88-$103. Wells Fargo coverage for the Charles Schwab Corp (SCHW) stock in a research note released on January 22, 2025 offered a Overweight rating with a price target of $93. Barclays was of a view on December 09, 2024 that the stock is Overweight, while Wells Fargo gave the stock Equal Weight rating on September 12, 2024, issuing a price target of $70. Piper Sandler on their part issued Neutral rating on July 29, 2024.
